Your browser doesn't support javascript.
loading
Chlorhexidine and Mupirocin Susceptibility of Methicillin-Resistant Staphylococcus aureus Isolates in the REDUCE-MRSA Trial.
Hayden, Mary K; Lolans, Karen; Haffenreffer, Katherine; Avery, Taliser R; Kleinman, Ken; Li, Haiying; Kaganov, Rebecca E; Lankiewicz, Julie; Moody, Julia; Septimus, Edward; Weinstein, Robert A; Hickok, Jason; Jernigan, John; Perlin, Jonathan B; Platt, Richard; Huang, Susan S.
Afiliación
  • Hayden MK; Department of Medicine (Infectious Diseases), Rush University Medical Center, Chicago, Illinois, USA mhayden@rush.edu.
  • Lolans K; Department of Pathology, Rush University Medical Center, Chicago, Illinois, USA.
  • Haffenreffer K; Department of Pathology, Rush University Medical Center, Chicago, Illinois, USA.
  • Avery TR; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA.
  • Kleinman K; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA.
  • Li H; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA.
  • Kaganov RE; Department of Pathology, Rush University Medical Center, Chicago, Illinois, USA.
  • Lankiewicz J; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA.
  • Moody J; Department of Population Medicine, Harvard Medical School and Harvard Pilgrim Health Care Institute, Boston, Massachusetts, USA.
  • Septimus E; Hospital Corporation of America, Nashville, Tennessee, USA.
  • Weinstein RA; Division of Internal Medicine, Texas A&M Health Science Center College of Medicine, Houston, Texas, USA.
  • Hickok J; Department of Medicine (Infectious Diseases), Rush University Medical Center, Chicago, Illinois, USA.
  • Jernigan J; Cook County Health and Hospitals System, Chicago, Illinois, USA.
  • Perlin JB; Hospital Corporation of America, Nashville, Tennessee, USA.
  • Platt R; Office of HAI Prevention Research and Evaluation, Centers for Disease Control and Prevention, Atlanta, Georgia, USA.
  • Huang SS; Hospital Corporation of America, Nashville, Tennessee, USA.
J Clin Microbiol ; 54(11): 2735-2742, 2016 11.
Article en En | MEDLINE | ID: mdl-27558180
Asunto(s)
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Clorhexidina / Mupirocina / Farmacorresistencia Bacteriana / Staphylococcus aureus Resistente a Meticilina Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: J Clin Microbiol Año: 2016 Tipo del documento: Article País de afiliación: Estados Unidos
Texto completo
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Clorhexidina / Mupirocina / Farmacorresistencia Bacteriana / Staphylococcus aureus Resistente a Meticilina Tipo de estudio: Clinical_trials Límite: Humans Idioma: En Revista: J Clin Microbiol Año: 2016 Tipo del documento: Article País de afiliación: Estados Unidos